Publications by authors named "Parker D Robinson"
Article Synopsis
- Anti-TNF therapeutics are crucial for treating autoimmune diseases by targeting tumor necrosis factor (TNF) to block harmful signaling pathways.
- Current testing methods for monitoring these drugs are complex and costly, hindering point-of-care use and regular patient monitoring.
- A new, simplified immunoassay using a tri-part split-luciferase system was developed, allowing for effective detection of anti-TNF drugs, leading to more frequent monitoring and potentially better patient outcomes.
